Pre-earnings options volume in Protagonist Therapeutics is normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 4.4%, or $1.06, after results are released. Median move over the past eight quarters is 1.9%.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PTGX:
- 3 Stocks to Buy Today, 3/16/2023, According to Top Analysts
- Protagonist Therapeutics participates in a conference call with JPMorgan
- Protagonist Therapeutics announces results from withdrawal portion of REVIVE
- Protagonist Therapeutics options imply 3.7% move in share price post-earnings
- Protagonist views exposure to liquidity concern at SVB as ‘limited’
